Response to a Randomized Trial on Mannitol Use During Partial Nephrectomy

JAMA Surg. 2021 Nov 1;156(11):1064-1066. doi: 10.1001/jamasurg.2021.3598.

Authors

Patrick Lewicki¹, Spyridon P Basourakos¹, Yuqing Qiu², Camilo Arenas-Gallo³, Douglas S Scherr¹, Lee E Ponsky³, Jonathan E Shoag^{1

3}

Affiliations

¹ Department of Urology, NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York.
² Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
³ Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Abstract

This study estimates the real-world surgical practice response to a randomized clinical trial on mannitol use during partial nephrectomy.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Databases, Factual
Diuretics, Osmotic / administration & dosage*
Furosemide / administration & dosage
Humans
Mannitol / administration & dosage*
Nephrectomy / adverse effects*
Practice Patterns, Physicians'*
Renal Insufficiency / etiology
Renal Insufficiency / prevention & control*
Retrospective Studies
United States

Substances

Diuretics, Osmotic
Mannitol
Furosemide